Persistent left vertical vein: An unusual cause of pulmonary hypertension and cirrhosis in a patient with hypertrophic obstructive cardiomyopathy

Código QR

Persistent left vertical vein: An unusual cause of pulmonary hypertension and cirrhosis in a patient with hypertrophic obstructive cardiomyopathy

Guardado en:

Detalles Bibliográficos
Autores principales:	Umut Karabulut, Egemen Duygu, Yeşim Yılmaz Can, İrem Sezer, Tuğrul Okay
Formato:	article
Lenguaje:	EN
Publicado:	KARE Publishing 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/18b13733cda54d35b6f5b6669a86aa91
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Unexpected complication of septal ablation 22 years later, septal diverticule with thrombus
por: İrem Okçular Sezer, et al.
Publicado: (2021)

Management of Hypertrophic Cardiomyopathy
por: Alan D. Enriquez, et al.
Publicado: (2014)

Left ventricular non-compaction with hypertrophic cardiomyopathy, a mutually beneficial combination?
por: Vijayaraghavan Govindan, et al.
Publicado: (2021)

Hypertrophic Cardiomyopathy with a Twist
por: W. Francis, et al.
Publicado: (2021)

Homeostatic Left Heart integration and disintegration links atrio-ventricular covariation’s dyshomeostasis in Hypertrophic Cardiomyopathy
por: Paolo Piras, et al.
Publicado: (2017)

Hypertrophic Cardiomyopathy in South Western Nigeria
por: Amam Mbakwem, et al.
Publicado: (2017)

Feline hypertrophic cardiomyopathy: an echocardiographic approach
por: Silva,AC, et al.
Publicado: (2013)

COVID-19 in Adults With Hypertrophic Cardiomyopathy
por: Milla E. Arabadjian, et al.
Publicado: (2021)

Characteristics of left atrial remodeling in patients with atrial fibrillation and hypertrophic cardiomyopathy in comparison to patients without hypertrophy
por: Sotirios Nedios, et al.
Publicado: (2021)

Sex differences in the prognosis of patients with hypertrophic cardiomyopathy
por: Minkwan Kim, et al.
Publicado: (2021)

Hypertrophic cardiomyopathy: a modern view of the problem
por: Amina M. Alieva, et al.
Publicado: (2020)

Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy
por: Styliani Vakrou, et al.
Publicado: (2021)

Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy
por: Maike Schuldt, et al.
Publicado: (2021)

Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
por: Elena V. Filatova, et al.
Publicado: (2021)

Overlap phenotypes of the left ventricular noncompaction and hypertrophic cardiomyopathy with complex arrhythmias and heart failure induced by the novel truncated DSC2 mutation
por: Yubi Lin, et al.
Publicado: (2021)

Clinical predictors of the presence of obstructive sleep apnea in patients with hypertrophic cardiomyopathy
por: Haobo Xu, et al.
Publicado: (2021)

Atrioventricular nodal ablation and left bundle branch pacing for treatment of refractory atrial fibrillation post alcohol septal ablation for hypertrophic obstructive cardiomyopathy
por: Rory Gallen, MB, BcH, BAO, et al.
Publicado: (2021)

Left ventricular noncompaction cardiomyopathy
por: Amer Hawatmeh, et al.
Publicado: (2017)

Correlation of miR-146a-5p plasma levels and rs2910164 polymorphism with left ventricle outflow tract obstruction in hypertrophic cardiomyopathy
por: Dimitrios Ntelios, et al.
Publicado: (2021)

Serum N-terminal pro-B-type natriuretic peptide levels are associated with left atrial dilation, resting left ventricular outflow tract gradient, and pulmonary hypertension in patients with hypertrophic cardiomyopathy
por: Adam Gębka, et al.
Publicado: (2020)

Identification of key proteins and lncRNAs in hypertrophic cardiomyopathy by integrated network analysis
por: Xiaofeng Hu, et al.
Publicado: (2019)

Analysis of the Serum Peptidomics Profile for Cats With Sarcomeric Gene Mutation and Hypertrophic Cardiomyopathy
por: Pratch Sukumolanan, et al.
Publicado: (2021)

Correlations between low thyroid function and incidence of atrial fibrillation in hypertrophic obstructive cardiomyopathy
por: Li-Min Liu, et al.
Publicado: (2020)

Prevalence, functional characteristics, and clinical significance of right ventricular involvement in patients with hypertrophic cardiomyopathy
por: Jiwon Seo, et al.
Publicado: (2020)

β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity
por: Arjun S. Adhikari, et al.
Publicado: (2019)

Loss of embryonic neural crest derived cardiomyocytes causes adult onset hypertrophic cardiomyopathy in zebrafish
por: Sarah Abdul-Wajid, et al.
Publicado: (2018)

Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition
por: Julien Robert-Paganin, et al.
Publicado: (2018)

Sudden cardiac death risk in hypertrophic cardiomyopathy: comparison between echocardiography and magnetic resonance imaging
por: Mateusz Śpiewak, et al.
Publicado: (2021)

Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes
por: Bradley A. Maron, et al.
Publicado: (2021)

Selective Interventricular Septal Radiofrequency Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy: Who Can Benefit?
por: Qiang Liu, et al.
Publicado: (2021)

Conduction abnormalities post alcohol septal ablation for hypertrophic cardiomyopathy – A single center experience
por: Avinash Mani, et al.
Publicado: (2021)

Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy
por: Sarinya Puwanant, et al.
Publicado: (2021)

A Rare Termination of Left Common Facial Vein into Left Subclavian Vein: A Case Report
por: Prakash,Babu B, et al.
Publicado: (2007)

An Unusual Termination of Seven Veins in the Jugulo-Subclavian Junction
por: Panagouli,Eleni, et al.
Publicado: (2009)

Left-sided Gallbladder: An Unusual Intraoperative Finding
por: Rasul Uzdenov, et al.
Publicado: (2021)

A genetic polymorphism in P2RY 1 impacts response to clopidogrel in cats with hypertrophic cardiomyopathy
por: Yu Ueda, et al.
Publicado: (2021)

Comparison of mitral regurgitation severity assessments based on magnetic resonance imaging and echocardiography in patients with hypertrophic cardiomyopathy
por: Mateusz Śpiewak, et al.
Publicado: (2021)

Global microRNA profiling of the mouse ventricles during development of severe hypertrophic cardiomyopathy and heart failure.
por: Richard D Bagnall, et al.
Publicado: (2012)

The Echocardiographic Parameters of Systolic Function Are Associated with Specific Metabolomic Fingerprints in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy
por: Martino Deidda, et al.
Publicado: (2021)

Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy
por: Christina Doesch, et al.
Publicado: (2017)